Ironfist Therapeutics’ 177Lu — Tamrada™ Doubles Survival with Anti — PD — 1 Therapy in Checkpoint — Resistant Pancreatic Cancer Model
For best results when printing this announcement, please click on link below: Ironfist Therapeutics’ (177)Lu-Tamrada™ Doubles Survival with Anti-PD-1 Therapy in Checkpoint-Resistant Pancreatic Cancer Model Tamrada Theranostic Pair, (64)Cu PET Imaging Agent and (177)Lu Therapeutic Agent, Progressing to Clinical Trials (